Inavolisib-Based Therapy Boosts Progression-Free Survival in Breast Cancer
Inavolisib-based therapy reaches the primary end point of the phase 3 INAVO120 study among patients with PIK3CA-mutated breast cancer.
Empowering Awareness to Address Rising Gynecological Cancer Incidence
Ginger J. Gardner, MD, FACOG, highlights disease prevention innovations and other ongoing efforts to empower education in the gynecologic cancer field.
Atezolizumab/Matched-Targeted Therapy Improves OS in Anaplastic Thyroid Cancer
Patients with anaplastic thyroid cancer had a significant boost to overall survival with atezolizumab and targeted therapy.
Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
A panel of expert pharmacists provides their perspectives on gene therapy agents such as exagamglogene autotemcel in the management of sickle cell disease.
Perioperative Chemo/IO Yields Promise as Long-Term Treatment for NSCLC
Patients with non–small cell lung cancer had a positive long-term benefit with perioperative chemoimmunotherapy, according to the 5-year NADIM trial update.
Approaching End-of-Life Discussions With Directness and Compassion
Kelley A. Rone, DNP, RN, AGNP-c, highlights how to best approach end-of-life discussions with patients receiving treatment for cancer.